Please login to read the full article.
Scrip Regulatory Affairs
US FDA panel says silicone breast implants are safe but calls for better post-marketing surveillance
02 September 2011
Madeleine Armstrong
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU panel plans to report on safety of PIP implants by month end as criticism of system continues
- Australian Senate panel inquiry expresses shock at patient experiences with DePuy hip devices; calls for stricter regulations
- Prometheus dissected: Will chaos rule in US patenting?
- US IOM calls for more global collaboration to protect drug supply
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
